Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.7.0.1
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2017
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the number of common shares potentially issuable upon the exercise of certain warrants, convertible notes payable and convertible interest as of March 31, 2017 and 2016 that have been excluded from the calculation of diluted net loss per common share since the effect would be antidilutive.

 

    March 31, 2017     March 31, 2016  
Warrants -Weighted avg exercise price $4.95     9,072,032       9,506,304  
Convertible notes - Weighted avg conversion price $0.67     5,233,684       3,772,674  
Accrued interest on convertible notes     475,137       178,770  
Total     14,780,863       13,457,748